Sernova Biotherapeutics Inc. (OTCMKTS:SEOVF) Shares Shorted: Short Interest Down 41.9% in October

Sernova Biotherapeutics Inc. (OTCMKTS:SEOVF – Get Free Report) saw a large decline in short interest in October. As of October 30th, there was short interest totaling 56,877 shares, a decline of 41.9% from the October 15th total of 97,838 shares. Based on an average daily trading volume, of 44,025 shares, the short-interest ratio is presently 1.3 days. Approximately 0.0% of the shares of the stock are sold short.

Sernova Biotherapeutics Price Performance

SEOVF stock opened at $0.07 on Wednesday. Sernova Biotherapeutics has a 12 month low of $0.06 and a 12 month high of $0.14. The firm has a 50 day simple moving average of $0.08 and a 200 day simple moving average of $0.10.

Sernova Biotherapeutics (OTCMKTS:SEOVF – Get Free Report) last announced its earnings results on Thursday, September 10th. The company reported ($0.01) earnings per share (EPS) for the quarter, meeting the consensus estimate of ($0.01).

Sernova Biotherapeutics Company Profile

(Get Free Report)

Sernova Biotherapeutics is a Canadian biotechnology company developing regenerative medicine technologies that use therapeutic cells to treat chronic diseases. Its primary platform, the Cell Pouch System, is an implantable device designed to support blood-vessel growth around transplanted cells. The company has focused on combining the Cell Pouch with insulin-producing islet cells as a potential treatment for type 1 diabetes. Its research has also included cell-based approaches for other conditions, such as thyroid disease and hemophilia.

Further Reading

Receive News & Ratings for Sernova Biotherapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sernova Biotherapeutics and related companies with MarketBeat.com's FREE daily email newsletter.